These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2827345)

  • 21. Treatment for visceral leishmaniasis.
    Thakur CP
    J Assoc Physicians India; 1987 Sep; 35(9):641-3. PubMed ID: 2830224
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan.
    Mueller M; Balasegaram M; Koummuki Y; Ritmeijer K; Santana MR; Davidson R
    J Antimicrob Chemother; 2006 Oct; 58(4):811-5. PubMed ID: 16916865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis.
    Manna L; Vitale F; Reale S; Caracappa S; Pavone LM; Morte RD; Cringoli G; Staiano N; Gravino AE
    Vet Parasitol; 2004 Nov; 125(3-4):251-62. PubMed ID: 15482882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Kala-azar imported from Yugoslavia].
    Rast HP; Marti HR
    Schweiz Med Wochenschr; 1986 Feb; 116(8):252-4. PubMed ID: 3006237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
    Das VN; Ranjan A; Bimal S; Siddique NA; Pandey K; Kumar N; Verma N; Singh VP; Sinha PK; Bhattacharya SK
    Natl Med J India; 2005; 18(3):131-3. PubMed ID: 16130613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pentostam the drug of choice in visceral leishmaniasis in Egypt.
    Soliman MS; Morsy TA; Abdel Messih MS; el Missiry AG
    J Egypt Soc Parasitol; 1984 Dec; 14(2):311-20. PubMed ID: 6096451
    [No Abstract]   [Full Text] [Related]  

  • 27. Canine leishmaniosis.
    Sapierzyński R
    Pol J Vet Sci; 2008; 11(2):151-8. PubMed ID: 18683546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony.
    Murray HW; Berman JD; Wright SD
    J Infect Dis; 1988 May; 157(5):973-8. PubMed ID: 2834469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of experimental cutaneous leishmaniasis by liposome-entrapped Pentostam.
    New RR; Chance ML
    Acta Trop; 1980 Sep; 37(3):253-6. PubMed ID: 6106363
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate.
    Chulay JD; Fleckenstein L; Smith DH
    Trans R Soc Trop Med Hyg; 1988; 82(1):69-72. PubMed ID: 2845611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A standardized cytological and immunochemical method for the analysis of fine-needle spleen aspirates: assessment of leukocyte population changes in canine visceral leishmaniosis.
    Barrouin-Melo SM; Larangeira DF; Santos SO; Chagas-Júnior AD; Paixão M; Aguiar PH; dos-Santos WL; Pontes-de-Carvalho L
    Vet Immunol Immunopathol; 2006 Jun; 111(3-4):251-61. PubMed ID: 16546267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol.
    Chunge CN; Gachihi G; Muigai R; Wasunna K; Rashid JR; Chulay JD; Anabwani G; Oster CN; Bryceson AD
    Trans R Soc Trop Med Hyg; 1985; 79(5):715-8. PubMed ID: 3006296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.
    Moore E; O'Flaherty D; Heuvelmans H; Seaman J; Veeken H; de Wit S; Davidson RN
    Bull World Health Organ; 2001; 79(5):388-93. PubMed ID: 11417033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parasitological diagnosis of canine visceral leishmaniasis: is intact skin a good target?
    Madeira MF; Figueiredo FB; Pinto AG; Nascimento LD; Furtado M; Mouta-Confort E; de Paula CC; Bogio A; Gomes MC; Bessa AM; Passos SR
    Res Vet Sci; 2009 Oct; 87(2):260-2. PubMed ID: 19364614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyarthritis associated with visceral leishmaniasis in a juvenile dog.
    Santos M; Marcos R; Assunção M; Matos AJ
    Vet Parasitol; 2006 Nov; 141(3-4):340-4. PubMed ID: 16824686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Successful treatment of antimony-resistant cutaneous leishmaniasis].
    Kremsner P; Lang I; Kollaritsch H
    Hautarzt; 1987 Dec; 38(12):733-5. PubMed ID: 2830206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complications of kala azar and its treatment in Kenya.
    Chunge CN; Gachihi G; Chulay JD; Spencer HC
    East Afr Med J; 1984 Feb; 61(2):120-7. PubMed ID: 6088210
    [No Abstract]   [Full Text] [Related]  

  • 38. Sodium antimony resistant cases of kala-azar in and around Patna (south Bihar).
    Sehgal PN; Murmu C; Chatteyee AK
    J Commun Dis; 1988 Jun; 20(2):161-2. PubMed ID: 2853714
    [No Abstract]   [Full Text] [Related]  

  • 39. Antimony-induced cerebellar ataxia.
    Khalil EA; Ahmed AE; Musa AM; Hussein MH
    Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visceral Leishmaniasis in children in the Yemen.
    Haidar NA; Diab AB; El-Sheik AM
    Saudi Med J; 2001 Jun; 22(6):516-9. PubMed ID: 11426243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.